Login
Navigate Fool.com
Will BCR beat
the market?

C.R. Bard, Inc.

NYSE: BCR

Community Rating: 4 Stars: Favorite

139.49 0.23 (0.17%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $138.89
Previous Close $139.26
Daily Range $138.51 - $140.60
52-Week Range $97.61 - $150.13
Market Cap $10.8B
P/E Ratio 16.63
Dividend (Yield) $0.84 (0.6%)
Ex-Dividend Date
Dividend Pay Date
04/24/14
05/09/14
Volume 555,554
Average Daily Volume 844,960
Current FY EPS $8.25

How do you think BCR
will perform against the market?

Top BCR Bull/Bear Pitches

 

woppi (< 20)
Submitted October 5, 2009

Low debt, high profit margins for the industry (just under 20%) and a nice steady increase in Total Cash from Operations down through the years. Operating expenses have also risen over the same period … More

0 Replies Reply Report this Post
 

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches here!

News & Commentary Rss Feed

High Expectations for Growth: Is CR Bard Overvalued?

Bard has significantly improved its growth outlook, but Wall Street seems a step or two ahead.

Dollar Tree Moves Up In Market Cap Rank, Passing C.R. Bard

After-Hours Earnings Report for January 30, 2014 : GOOG, AMZN, CNI, MCK, CB, WYNN, CMG, BRCM, EMN,

After-Hours Earnings Report for January 30, 2014 : GOOG, AMZN, CNI, MCK, CB, WYNN, CMG, BRCM, EMN, BCR, MCHP, CSC

Risk and Cycles: Looking at Buybacks, Debt, Cash

Weekly Insider Sells Highlight: BCR, GLUU, AMT, APOL, JACK

C.R. Bard, Inc. (BCR) Ex-Dividend Date Scheduled for January 16, 2014

Covidien No Longer Sneaking Up on the Market

Covidien has been a sector-beater for two years, but the Street seems to have caught up with the value and performance here.

Anti-Elitism: Beating The Dividend Aristocrats

Pentagon Awards $392 Million in Defense Contracts Monday

In addition to new awards announced, Pentagon reveals value of last week's airlift support contract award to AAR.

Here's Why Boston Scientific Bought C.R. Bard's Electrophysiology Business

Boston Scientific is cutting costs in a bid to return to profitability. So, why did the company spend $275 million to acquire the electrophysiology business from competitor C.R. Bard?

See More BCR News...

Sector

Healthcare

Industry

Healthcare Information Services

C.R. Bard, Inc. (BCR) Description

The Company is engaged in the design, manufacture, packaging, distribution and sale of medical, surgical, diagnostic and patient care devices. Website: http://www.crbard.com/

Featured Broker Partners

Learn more about our new Fool ticker page!

Take a Tour
no thanks